In vitro neutralization of hepatitis b virus by monoclonal antibodies against the viral surface antigen

Journal of Medical Virology

Volumn 52, Issue 2, 1997, Pages 226-233

  Ryu, Chun Jeih ^a   Gripon, Philippe ^b   Park, Heung Rok ^a   Park, Sung Sup ^a   Kim, Youn Kyu ^a   Guguen Guillouzo, Christiane ^b   Yoo, Ook Joon ^c   Hong, Hyo Jeong ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Anti preS1; Anti preS2; Anti S prophylaxis; In vitro HBV infection; Monoclonal antibodies; Neutralization

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; CHIMERA; CONTROLLED STUDY; HEPATITIS B VIRUS; IMMUNOPRECIPITATION; IN VITRO STUDY; NONHUMAN; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CHO CELLS; CRICETINAE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER; MICE; NEUTRALIZATION TESTS; PRECIPITIN TESTS; PROTEIN PRECURSORS; TUMOR CELLS, CULTURED;

CRICETINAE; CRICETULUS GRISEUS; HEPATITIS B VIRUS; MURINAE; PAN (APE);

EID: 0030927277     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199706)52:2<226::AID-JMV18>3.0.CO;2-I     Document Type: Article

References (46)

1. Beasley RP, Hwang LY, Lee CY, Lan CC, Roan CH, Huang FY, Chen CL (1983): Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2:1099-1102.
2. Beidler CB, Ludwig JR, Cardenas J, Phelps J, Papworth CG, Melcher E, Sierzega M, Myers L, Unger BW, Fisher M, David GS, Johnson MJ (1988): Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryogenic antigen. Journal of Immunology 141:4053-4060.
3. Bhatnager PK, Papas E, Blum HE, Milich DR, Nitecki D, Kareb MJ, Vyas GN (1982): Immune response to synthetic peptide analogues of HBsAg specific for the a determinant. Proceedings of National Academy of Sciences USA 79:4723-4727.
4. Budkowska A, Riottot M-M, Dubreuil P, Lazizi Y, Brechot C, Sobczak E, Petit M-A, Pillot J (1986): Monoclonal antibody recognizing preS(2) epitope of hepatitis B virus: Characterization of pre-S(2) epitope and anti-pre-S(2) antibody. Journal of Medical Virology 20: 11-125.
5. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (1991): In "Current Protocols in Immunology." National Institutes of Health.
6. Engvall E, Perlman P (1972): Enzyme-linked immunosorbent assay, ELISA, III. Quantitation of specific antibodies by enzyme labeled anti-immunoglobulin in antigen coated tubes. Journal of Immunology 109:129-135.
7. Gerin JL, Alexander H, Shih JW, Percell RH, Dapolito G, Engle R, Green N, Sutcliffe JG, Shinnick TM, Lerner RA (1983): Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees. Proceedings of National Academy of Sciences USA 80: 2365-2369.
8. Gripon P, Diot C, Guguen-Guillouzo C (1993): Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: Effect of polyethylene glycol on adsorption and penetration. Virology 192:534-540.
9. Guguen-Guillouzo C, Guillouzo A (1986): Methods of preparation of adult and fetal hepatocytes. In Guillouzo A, Guguen-Guillouzo C (eds): "Isolated and Cultured Hepatocytes." Paris: Les éditions IN-SERM, pp 1-12.
10. Harada K, Ichimori Y, Sasano K, Sasai S, Kitano K, Iwasa S, Tsukamoto K, Sugino Y (1989): Human-human hybridoma secreting hepatitis B virus-neutralizing antibodies. Bio/Technology 7:374-377.
11. Harlow E, Lane D (1988): "Antibodies: A Laboratory Manual." Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
12. Heerman KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH (1984): Large surface proteins of hepatitis B virus containing the pre-S sequence. Journal of Virology 52:392-402.
13. Hirt B (1967): Selective extraction of polyoma DNA from infected mouse cell cultures. Journal of Molecular Biology 26:365-369.
14. Hong HJ, Kim AK, Ryu CJ, Park SS, Chung HK, Kwon KS, Kim KL, Kim J, Han MH (1992): Cloning and characterization of cDNAs coding for heavy and light chains of a monoclonal antibody specific for pre-S2 antigen of hepatitis B virus. Gene 121:331-335.
15. Hoogenboom HR, Raus JC, Volckaert G (1990): Cloning and expression of a chimeric antibody directed against the human transferrin receptor. Journal of Immunology 144:3211-3217.
16. Itoh YE, Takai H, Ohnuma K, Kitayima F, Tsuda A, Machida S, Mishiro T, Nakamura Y, Miyakawa, Mayumi M (1986): A synthetic peptide vaccine involving the product of the preS2 region of hepatitis B virus: Protective efficacy in chimpanzees. Proceedings of National Academy of Sciences USA 83:9174-9178
17. Iwarson S, Tabor E, Thomas HC, Goodall A, Waters J, Snoy P, Shih J. W-K, Gerety RJ (1985): Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: An experimental study in the chimpanzee. Journal of Medical Virology 16:89-96.
18. Jin BR, Ryu CJ, Park SS, Namgung U, Hong HJ, Han MH (1993): Cloning, expression, and characterization of a murine-human chimeric antibody with specificity for the pre-S2 surface antigen of hepatitis B virus. Molecular Immunology 30:1647-1654.
19. Jin BR, Ryu CJ, Rang SK, Han MH, Hong HJ (1995): Characterization of a murine-human chimeric antibody with specificity for the pre-S2 surface antigen of hepatitis B virus expressed in baculovirus-infected insect cells. Virus Research 38:269-277.
20. Kim YK, Kim HS, Ryu CJ, Jin BR, Hong HJ (1996): Production and characterization of murine monoclonal antibody to hepatitis B virus preS1. Korean Journal of Immunology 18:367-373.
21. Kim YS, Kang HS (1984): Cloning and expression of hepatitis B virus surface antigen gene. Korean Biochemical Journal 17:70-79.
22. Laal S, Burda S, Gorny MK, Karwowska S, Buchbinder A, Zolla-Pazner S (1994): Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies. Journal of Virology 68:4001-4008.
23. Li Y-W, Lawrie DK, Thammana P, Moore GP, Shearman CW (1990): Construction, expression and characterization of a murine-human chimeric antibody with specificity for hepatitis B surface antigen. Molecular Immunology 27:303-311.
24. Machida A, Kishimoto S, Ohnuma H, Baba K, Itoh Y, Miyamoto H, Funatsu G, Oda K, Usuda S, Togami S, Nakamura T, Miyakawa Y, Mayumi M (1984): A polypeptide containing 55 amino acids residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acids bears the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 86:910-918.
25. Mandel B (1985): Virus neutralization. In Van Regenmortel MHV, Neurath AR (eds): "Immunochemistry of Viruses." Amsterdam: Elsevier Biomedical Press, pp 53-70.
26. Milich DR, McNamare MK, McLachlan A, Thornton GB, Chisari VF (1985): H2-linked regulation of T cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region. Proceedings of National Academy of Sciences USA 82:8168-8172.
27. Milich DR, McLachlan A, Chisari FV, Kent SBH, Thornton GB (1986): Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): A preS1-specific T cell response can bypass non-responsiveness to the pre-S(2) and S regions of HBsAg. Journal of Immunology 137:315-322.
28. Morrison SL (1985): Transfectomas provide novel chimeric antibodies. Science 229:1202-1207.
29. Neurath AR, Kent SBH, Strick N, Stark D, Sproul P (1985): Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the preS2 region of hepatitis B virus envelope gene. Journal of Medical Virology 17:119-125.
30. Neurath AR, Kent SBH, Strick N, Parker K (1986a): Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429-436.
31. Neurath AR, Seto B, Parker K, Prince AM, Strich N, Brotman B, Sproul P (1986b): Antibodies to synthetic peptides from the preS 120-145 region of the hepatitis B virus envelope are virus-neutralizing. Vaccine 4:35-37.
32. Neurath AR, Seto B, Strich N (1989): Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus envelope proteins are virus-neutralizing and protective. Vaccine 7:234-236.
33. Ogata N, Ostberg L, Ehrlich PH, Wong DC, Miller RH, Percell RH (1993): Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the α determinant of hepatitis B surface antigen. Proceedings of National Academy of Sciences USA 90:3014-3018.
34. Petit MA, Dubanchet S, Capel F, Voet P, Dauguet C, Hauser P (1991): HepG2 cell binding activities of different hepatitis B virus isolates: Inhibitory effect of anti-HBs and anti-preS1 (21-47). Virology 180: 483-491.
35. Pontisso P, Ruvoletto MG, Gerlich WH, Heerman KH, Bardini R, Alberti A (1989): Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology 173:522-530.
36. Potts BJ, Field KG, Wu Y, Posner M, Cavacini L, White-Scharf M (1993): Synergistic inhibition of HIV-1 by CD4 binding domain reagents and V3 directed monoclonal antibodies. Virology 197: 415-419.
37. Purcell RH, Gerin JL (1985): Prospects for second and third generation hepatitis B vaccines. Hepatology 5:159-163.
38. Ryu CJ, Jin BR, Chung HK, Han MH, Hong HJ (1994): Cloning and Characterization of cDNAs coding for heavy and light chains of a monoclonal antibody specific for the S antigen of hepatitis B virus. Gene 144:313-314.
39. Ryu CJ, Padlan EA, Jin BR, Yoo OJ, Hong HJ (1996): A humanized antibody with specificity for Hepatitis B surface antigen. Human Antibodies and Hybridomas. In press.
40. Sells MA, Chen M-L, Acs G (1987): Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proceedings of National Academy of Sciences USA 84:1005-1009.
41. Southern EM (1975): Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98:503-517.
42. Subramani S, Mulligan R, Berg P (1981): Expression of the mouse dihydrofolate reductase complementary deoxmyribonucleic acids in Simian virus 40 vectors. Molecular Cellular Biology 1:854-864.
43. Suiata V-W, Pinter A, Honnen WJ, Tilley SA (1996): Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site. Journal of Virology 70:4466-4473.
44. Sun LK, Curtis P, Rakowiez-Szulczynska E, Ghrayeb J, Chang N, Morrison SL, Koprowsky H (1987): Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A. Proceedings of National Academy of Sciences USA 84:214-218.
45. Todo S, Demetris AJ, Thiel DV, Teperman L, Fung JJ, Starzel TE (1991 ): Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 13:619-626.
46. Wands JR, Ben-Porath E, Wong EA (1984): Monoclonal antibodies and hepatitis B: A new perspective using highly sensitive and specific radioimmunoassays. In Vyas GN, Dienstag JL Hoofnagle JH (eds): "Viral Hepatitis and Liver Disease." New York: Grune and Stratton, pp 543-559.